Video
2 Sep 2024
ChemExpress One-stop CRO & CDMO Service
JPG 222 kB
Founded in 2006, ChemExpress focuses on providing small molecule and new modalities CDMO services for both pharmaceutical and biotech clients. Our comprehensive CRO & CDMO platform is engaged in the research and development, manufacturing and supply of regulatory starting materials, novel building blocks, intermediates, reference compounds, APIs and drug products. We are a one-stop service platform to support our client’s projects from early drug discovery, process development to commercialization.
Content provided by our supplier
Shanghai Haoyuan
-
US -
2022On CPHI since
-
3Certificates
-
1000 - 4999Employees
Company types
Primary activities
.jpg){kind=link}
Other Content from Shanghai Haoyuan (1)
-
News ChemExpress have received EIR with the conclusion of the inspection
ChemExpress have received EIR with the conclusion of the inspection, no FDA 483, Observations, was issued by US FDA on August 8th.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance